Delivery of Financial Navigation Services Within National Cancer Institute-Designated Cancer Centers
- PMID: 34222790
- PMCID: PMC8242138
- DOI: 10.1093/jncics/pkab033
Delivery of Financial Navigation Services Within National Cancer Institute-Designated Cancer Centers
Abstract
Background: Cancer centers have a responsibility to help patients manage the costs of their cancer treatment. This article describes the availability of financial navigation services within the National Cancer Institute (NCI)-designated cancer centers.
Methods: Data were obtained from the NCI Survey of Financial Navigation Services and Research, an online survey administered to NCI-designated cancer centers from July to September 2019. Of the 62 eligible centers, 57 completed all or most of the survey, for a response rate of 90.5%.
Results: Nearly all cancer centers reported providing help with applications for pharmaceutical assistance programs and medical discounts (96.5%), health insurance coverage (91.2%), assistance with nonmedical costs (96.5%), and help understanding medical bills and out-of-pocket costs (85.9%). Although other services were common, in some cases they were only available to certain patients. These services included direct financial assistance with medical and nonmedical costs and referrals to outside organizations for financial assistance. The least common services included medical debt management (63.2%), detailed discussions about the cost of treatment (54.4%), and guidance about legal protections (50.1%). Providing treatment cost transparency to patients was reported as a common challenge: 71.9% of centers agreed or strongly agreed that it is difficult to determine how much a cancer patient's treatment will cost, and 70.2% of oncologists are reluctant to discuss financial issues with patients.
Conclusions: Cancer centers provide many financial services and resources. However, there remains a need to build additional capacity to deliver comprehensive financial navigation services and to understand the extent to which patients are referred and helped by these services.
Published by Oxford University Press 2021. This work is written by US Government employees and is in the public domain in the US.
Figures
Similar articles
-
Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics.JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad055. doi: 10.1093/jncics/pkad055. JNCI Cancer Spectr. 2023. PMID: 37561111 Free PMC article.
-
Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions.J Natl Compr Canc Netw. 2020 Jul;18(7):825-831. doi: 10.6004/jnccn.2020.7538. J Natl Compr Canc Netw. 2020. PMID: 32634772
-
Relation Between Narrow Networks and Providers of Cancer Care.J Clin Oncol. 2017 Sep 20;35(27):3131-3135. doi: 10.1200/JCO.2017.73.2040. Epub 2017 Jul 5. J Clin Oncol. 2017. PMID: 28678667 Free PMC article.
-
Defining the Role of the Modern Oncology Provider in Mitigating Financial Toxicity.J Am Coll Radiol. 2023 Jan;20(1):51-56. doi: 10.1016/j.jacr.2022.10.011. Epub 2022 Dec 10. J Am Coll Radiol. 2023. PMID: 36513257 Free PMC article. Review.
-
The financial burden of cancer care: do patients in the US know what to expect?Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):835-42. doi: 10.1586/14737167.2014.963558. Epub 2014 Oct 1. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 25269513 Review.
Cited by
-
The Role of Social Support in Buffering the Financial Toxicity of Breast Cancer: A Qualitative Study of Patient Experiences.Cancers (Basel). 2025 May 20;17(10):1712. doi: 10.3390/cancers17101712. Cancers (Basel). 2025. PMID: 40427208 Free PMC article.
-
"I wish I knew about these programs before!" A brief report exploring barriers to financial assistance reported by gynecological oncology patients.J Psychosoc Oncol. 2023;41(5):493-501. doi: 10.1080/07347332.2022.2149374. Epub 2022 Dec 14. J Psychosoc Oncol. 2023. PMID: 36514954 Free PMC article.
-
Core functions of a financial navigation intervention: An in-depth assessment of the Lessening the Impact of Financial Toxicity (LIFT) intervention to inform adaptation and scale-up in diverse oncology care settings.Front Health Serv. 2022 Nov 9;2:958831. doi: 10.3389/frhs.2022.958831. eCollection 2022. Front Health Serv. 2022. PMID: 36925862 Free PMC article.
-
Perceived Appropriateness of Assessing for Health-related Socioeconomic Risks Among Adult Patients with Cancer.Cancer Res Commun. 2023 Apr 3;3(4):521-531. doi: 10.1158/2767-9764.CRC-22-0283. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37020993 Free PMC article.
-
Self-Reported Financial Difficulties Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia Treated at U.S. Community Oncology Clinics (Alliance A231602CD).medRxiv [Preprint]. 2024 Sep 18:2024.09.13.24311098. doi: 10.1101/2024.09.13.24311098. medRxiv. 2024. Update in: BMJ Open. 2025 Jun 3;15(6):e091769. doi: 10.1136/bmjopen-2024-091769. PMID: 39371185 Free PMC article. Updated. Preprint.
References
-
- Gordon N, Stemmer SM, Greenberg D, et al.Trajectories of injectable cancer drug costs after launch in the United States. J Clin Oncol. 2018;36(4):319–325. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical